Today's Low
₹ 686.35
Today's High
₹ 695.75
52 Weeks Low
₹ 548.25
52 Weeks High
₹ 945.00
Lower
₹ 546.65
Upper
₹ 819.95
MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It offers pharmaceutical and wellness products, including medicines, vitamins, medical devices, and test kits; fast-moving consumer goods, such as toiletries, baby care products, soaps, detergents, and sanitizers. The company also provides wholesale cash and carry, and pathological laboratory testing services, as well as engages in the contract manufacturing of private label pharmaceuticals. As of March 31, 2021, it operated through 1,659 stores located in the states of Karnataka, Tamil Nadu, Telangana, and Andhra Pradesh, as well as through its online store. The company was incorporated in 2006 and is based in Hyderabad, India.
No Data Found
No of shares Outstanding
EPS-TTM
Face Value
Book Value
Net Asset Value
ROE
ROA
ROCE
Dividend Yield
Total Debt
Sales Growth
PAT Growth
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 1,480.7 | 1,631.7 | 953.0 | 815.8 | 474.8 | 457.5 | 394.9 | 376.4 | 317.0 |
Total Non-Current Assets | 1,283.8 | 992.0 | 604.0 | 492.8 | 166.5 | 152.2 | 129.7 | 124.5 | 113.2 |
Total Assets | 2,764.5 | 2,623.7 | 1,557.0 | 1,308.5 | 641.3 | 609.7 | 524.6 | 501.0 | 430.2 |
Total Current Liabilities | 476.6 | 559.0 | 444.8 | 481.1 | 336.9 | 325.5 | 276.4 | 269.2 | 210.1 |
Total Non-Current Liabilities | 797.4 | 647.4 | 381.0 | 298.4 | -20.8 | -19.3 | 87.9 | 82.3 | 66.5 |
Shareholder's Funds | 1,491.2 | 1,417.8 | 730.6 | 527.8 | 325.2 | 303.5 | 160.3 | 149.5 | 153.6 |
Total Liabilities | 2,764.5 | 2,623.7 | 1,557.0 | 1,308.5 | 641.3 | 609.7 | 524.6 | 501.0 | 430.2 |
The Industry Price to BV stands at 6.03, vs the Price to BV of 5.38, which results in a Negative aspect.
The Industry Debt to Equity Ratio stands at 0.22, vs the Debt to Equity Ratio of 0.20, which results in a Positive aspect.
The Industry Current Ratio stands at 2.31, vs the Current Ratio of 1.67, which results in a Negative aspect.
The Industry Quick Ratio stands at 1.60, vs the Quick Ratio of 0.38, which results in a Negative aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
---|---|---|---|---|---|---|---|---|---|
Total Income | 4,557.6 | 3,779.3 | 3,069.3 | 2,870.6 | 2,272.7 | 2,131.8 | 2,011.3 | 1,732.8 | 1,368.3 |
Total Expenditure | 4,276.2 | 3,490.4 | 2,840.1 | 2,736.9 | 2,215.9 | 2,073.2 | 1,934.8 | 1,691.4 | 1,332.6 |
Operating Profit(Excl OI) | 327.4 | 320.3 | 250.8 | 151.0 | 66.6 | 65.9 | 84.8 | 50.3 | 40.0 |
Add: Other Income | 46.1 | 31.4 | 21.6 | 17.3 | 9.8 | 7.2 | 8.3 | 8.9 | 4.3 |
Operating Profit | 327.4 | 320.3 | 250.8 | 151.0 | 66.6 | 65.9 | 84.8 | 50.3 | 40.0 |
Less: Interest | 98.7 | 82.9 | 67.4 | 46.8 | 16.1 | 27.7 | 25.4 | 21.7 | 17.5 |
PBDT | 228.7 | 237.3 | 183.4 | 104.2 | 50.5 | 38.1 | 59.4 | 28.6 | 22.5 |
Less: Depreciation Amortization | 181.6 | 119.4 | 88.3 | 74.8 | 14.0 | 12.5 | 11.5 | 9.9 | 8.7 |
PBT & Exceptional Items | 47.2 | 117.9 | 95.1 | 29.4 | 36.6 | 25.6 | 47.9 | 18.7 | 13.8 |
Less: Exceptional Income Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit Before Tax | 47.2 | 117.9 | 95.1 | 29.4 | 36.6 | 25.6 | 47.9 | 18.7 | 13.8 |
Less: Taxation | -2.9 | 23.2 | 32.0 | 27.6 | 15.7 | -16.7 | 19.1 | 9.6 | 6.3 |
Profit After Tax | 50.1 | 94.7 | 63.1 | 1.8 | 20.9 | 42.4 | 28.8 | 9.1 | 7.5 |
Earnings Per Share | 0.4 | 0.8 | 28.5 | 0.8 | 9.6 | 19.4 | 0.0 | 0.0 | 0.0 |
The Industry PAT Margin stands at 9.77, vs the PAT Margin of 0.06, which results in a Negative aspect.
The Industry Dividend Yield stands at 0.60, vs the Dividend Yield of 0.00, which results in a Negative aspect.
The Industry PE Ratio stands at 42.56, vs the PE Ratio of 141.39, which results in a Positive aspect.
The Industry PAT Growth stands at 32.18, vs the PAT Growth of -91.42, which results in a Negative aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
---|---|---|---|---|---|---|---|---|---|
Profit Before Tax | 47.2 | 117.9 | 95.1 | 29.4 | 36.6 | 25.6 | 47.9 | 18.7 | 13.8 |
Tax Paid | -13.9 | -33.6 | -28.7 | -14.9 | -12.5 | -23.4 | -15.9 | -10.1 | -10.2 |
Adjustment | 272.8 | 187.9 | 182.3 | 155.4 | 34.8 | 42.7 | 10.2 | 8.3 | 7.1 |
Changes In Working Capital | 47.2 | 117.9 | 95.1 | 29.4 | 36.6 | 25.6 | 47.9 | 18.7 | 13.8 |
Cash Flow after changes in Working Capital | 104.3 | 203.5 | 31.6 | 8.3 | 94.5 | 55.7 | 32.3 | -21.3 | -25.4 |
Cash Flow from Operating Activities | 90.4 | 169.9 | 2.9 | -6.6 | 82.0 | 32.3 | 33.8 | -17.1 | -18.6 |
Cash Flow from Investing Activities | 429.4 | -703.1 | -34.5 | -27.6 | -20.0 | -17.6 | -14.9 | -32.3 | -15.3 |
Cash Flow from Financing Activities | -170.2 | 440.4 | -5.6 | 89.8 | -72.1 | -0.9 | -29.2 | 34.6 | 65.9 |
Net Cash Inflow / Outflow | 349.6 | -92.8 | -37.3 | 55.7 | -10.1 | 13.9 | -10.4 | -14.8 | 31.9 |
Opening Cash & Cash Equivalents | -121.2 | -28.4 | 8.9 | -46.8 | 34.5 | 20.6 | 31.0 | 45.8 | 13.1 |
Closing Cash & Cash Equivalent | 228.4 | -121.2 | -28.4 | 8.9 | 24.5 | 34.5 | 20.6 | 31.0 | 45.1 |
The Industry PFCF Ratio stands at 25.12, vs the PFCF Ratio of 0.00, which results in a Negative aspect.
The Industry PCF RATIO stands at 24.29, vs the PCF RATIO of 0.00, which results in a Negative aspect.
Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 |
---|---|---|---|---|---|---|---|---|---|
Net Sales | 14,414.7 | 14,085.9 | 12,843.0 | 12,529.8 | 11,903.1 | 11,206.3 | 9,936.5 | 9,659.1 | 9,334.5 |
Total Income | 14,512.6 | 14,189.5 | 12,936.9 | 12,666.8 | 12,016.8 | 11,315.2 | 10,037.8 | 9,789.6 | 9,407.9 |
Total Expenditure | 13,496.9 | 13,235.0 | 12,129.5 | 11,713.5 | 11,185.9 | 10,609.6 | 9,410.1 | 9,136.3 | 8,720.2 |
PBIDT (Excl OI) | 917.8 | 850.9 | 713.4 | 816.3 | 717.2 | 596.7 | 526.4 | 522.8 | 614.3 |
Other Income | 97.9 | 103.7 | 93.9 | 136.9 | 113.6 | 108.9 | 101.3 | 130.5 | 73.3 |
Operating Profit | 1,015.7 | 954.6 | 807.4 | 953.2 | 830.8 | 705.6 | 627.7 | 653.2 | 687.7 |
Interest | 245.0 | 235.4 | 232.7 | 222.7 | 210.8 | 198.7 | 198.1 | 185.8 | 165.3 |
Exceptional Items | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
PBDT | 770.7 | 719.2 | 574.7 | 730.5 | 620.0 | 506.9 | 429.6 | 467.5 | 522.4 |
Depreciation | 571.1 | 554.7 | 524.2 | 558.0 | 457.9 | 418.7 | 381.0 | 341.1 | 304.8 |
Profit Before Tax | 199.6 | 164.4 | 50.5 | 172.5 | 162.1 | 88.2 | 48.7 | 126.3 | 217.5 |
Tax | 62.6 | 19.0 | 12.9 | -93.1 | 28.3 | 23.5 | 11.9 | 12.0 | 48.3 |
Provisions and contingencies | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit After Tax | 137.1 | 145.4 | 37.7 | 265.6 | 133.8 | 64.8 | 36.8 | 114.3 | 169.2 |
Net Profit | 137.1 | 145.4 | 37.7 | 265.6 | 133.8 | 64.8 | 36.8 | 114.3 | 169.2 |
ADDITIONAL INFOS: | |||||||||
Equity Capital | 239.1 | 238.7 | 238.6 | 238.6 | 238.6 | 238.6 | 238.6 | 238.6 | 238.6 |
Reserves | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
EPS | 1.2 | 1.2 | 0.3 | 2.2 | 1.1 | 0.6 | 0.3 | 1.0 | 1.5 |
Operating Profit Margin | 7.0 | 6.8 | 6.3 | 7.6 | 7.0 | 6.3 | 6.3 | 6.8 | 7.4 |
Net Profit Margin | 1.0 | 1.0 | 0.3 | 2.1 | 1.1 | 0.6 | 0.4 | 1.2 | 1.8 |
The Industry Mcap Growth stands at 19.69, vs the Mcap Growth of 0.00, which results in a Negative aspect.
The Industry Net Sales Growth stands at 11.07, vs the Net Sales Growth of 26.31, which results in a Positive aspect.
Type | Classic | Woodie | Camarilla |
---|---|---|---|
R4 | 734.10 | 751.81 | 705.32 |
R3 | 722.75 | 724.18 | 699.86 |
R2 | 711.40 | 712.11 | 698.04 |
R1 | 702.90 | 704.33 | 696.22 |
Pivot | 691.55 | 692.26 | 691.55 |
S1 | 683.05 | 684.48 | 692.58 |
S2 | 671.70 | 672.41 | 690.76 |
S3 | 663.20 | 664.63 | 688.94 |
S4 | 654.70 | 632.71 | 683.48 |
(All Values are in INR)
1 Day
1 Week
1 Month
Stoch RSI
69.03
Neutral
RSI
50.07
Neutral
ROC
-0.63
Bearish
UltimateOscillator
57.61
Neutral
Williams Indicator
-56.43
Neutral
CCI Indicator
41.84
Neutral
MACD
-2,414.40
Bearish
Stochastic Indicator
53.65
Neutral
ATR
20.48
High Volatility
Ex-Date | Ratio | Record Date |
---|
Ex-Date | Ratio | Record Date |
---|
Announcement Date | Dividend Amount | Dividend Percentage of FV | Dividend Type |
---|
Date Of Conduct | Board Meeting Details |
---|---|
28-05-2024 | Audited Results |
21-02-2024 | Inter alia, to discuss the management recommendation to not proceed with the approval for Qualified Institutional Placement (QIP) received from shareholders on November 30, 2023. |
02-02-2024 | Quarterly Results |
08-11-2023 | Quarterly Results (Revised) |
26-10-2023 | Quarterly Results |
11-10-2023 | Inter alia, to consider and evaluate proposal for raising of funds by the Company, by way of inter alio, issue of equity shares or any other equity linked instruments or securities including convertible preference shares/ fully or partly convertible debentures or by way of a composite issue of non-convertible debentures and warrants entitling the warrant holder(s) to apply for equity shares, or any other eligible securities through inter alio, a private placement (including one or more qualified institutions placements) or further public issue of equity/ debt securities, preferential issue or a rights issue or through any other permissible mode under applicable laws and/ or combination thereof, as may be considered appropriate, subject to such statutory/regulatory/other approvals as may be required, including the approval of the members, to seek their consent for such fund raising and to approve ancillary actions for such fund raising. The Board, would further convene an Extra-ordinary General Meeting or postal ballot to obtain the approval of shareholders for the above proposal, once approved by the Board. |
05-10-2023 | Inter alia, to consider and approve the Proposal for raising of funds by the Company |
07-08-2023 | Quarterly Results (Revised) |
01-08-2023 | Quarterly Results |
25-05-2023 | Audited Results |
11-05-2023 | Inter alia, to consider for approval of Members through Postal Ballot for the following business by way of Special Resolution: i. Approval for extending benefits of Employees Stock Option Plan 2023. to the employees of its Subsidiary Companies; and ii. Alteration of Articles of Association of the Company in relation to retain the Nomination Rights of the Promoters/Investors as per existing Articles of Association of the Company |
03-02-2023 | Quarterly Results |
11-11-2022 | Quarterly Results |
10-08-2022 | Quarterly Results |
30-05-2022 | Audited Results |
14-02-2022 | Quarterly Results |